{"url":"https://newsforagent.com/news/2026-11-06/gmm-pfaudler-ankit-nayyar-group-cfo","markdown_url":"https://newsforagent.com/news/2026-11-06/gmm-pfaudler-ankit-nayyar-group-cfo.md","title":"GMM Pfaudler Promotes Ankit Nayyar to Group CFO","headline":"GMM Pfaudler Elevates Ankit Nayyar to Group CFO After Deputy Role Since May","description":"GMM Pfaudler promoted Ankit Nayyar to Group CFO in November 2026 after his Deputy CFO tenure since May.","section":"Leadership","published_at":"2026-11-06T10:31:34+00:00","modified_at":"2026-11-06T10:31:34+00:00","author":"News Desk","key_takeaways":["Ankit Nayyar became GMM Pfaudler Group CFO in November 2026 after serving as Deputy CFO since May 2026.","Nayyar brings more than 18 years of finance experience, including roles at Bayer, Pfizer and Monsanto.","GMM Pfaudler reported Q2FY27 net profit of ₹35.13 crore, down 6.8% year-on-year, with order intake up 36%."],"companies":[{"name":"GMM Pfaudler","is_primary":true,"profile_url":"https://akta.pro/company-profiles/000kcb3/gmm-pfaudler","website":"http://www.gmmpfaudler.com"}],"source":{"publisher":"TradingView","title":"GMM Pfaudler Elevates Ankit Nayyar To Group CFO","url":"https://www.tradingview.com/news/moodys:4dd0710ba5371:0-gmm-pfaudler-elevates-ankit-nayyar-to-group-cfo/"},"other_sources":[],"tags":["Leadership","GMM Pfaudler"],"body_markdown":"GMM Pfaudler has elevated Ankit Nayyar to Group Chief Financial Officer effective November 2026, after he served as Deputy CFO since May 2026. [TradingView](https://www.tradingview.com/news/moodys:4dd0710ba5371:0-gmm-pfaudler-elevates-ankit-nayyar-to-group-cfo/) reported the appointment. Nayyar, a chartered accountant, brings more than 18 years of finance experience across pharmaceuticals, consumer health, agriculture, financial services and insurance.\n\n## Nayyar's Path to the Group Finance Role\n\nNayyar joined [GMM Pfaudler](https://akta.pro/company-profiles/000kcb3/gmm-pfaudler) as Deputy CFO in May 2026 and took over as Group CFO in November. His elevation marks a progression within the company's finance leadership.\n\nBefore joining GMM Pfaudler, Nayyar was Chief Financial Officer at PI Health Sciences from August 2023 to May 2026, where he led the finance function. He spent more than three years at Bayer as Head of Finance for Consumer Health from January 2020 to August 2023. Earlier, he worked at Monsanto Company as India Controller from April 2018 to December 2019 and as India Financial Planning and Analysis Lead from September 2016 to April 2018. His career also includes roles at Pfizer between 2013 and 2016 spanning finance business partnering, commercial finance management and commercial controllership.\n\nNayyar is a chartered accountant from the Institute of Chartered Accountants of India and holds a Bachelor of Commerce degree from Shri Ram College of Commerce, University of Delhi. His experience covers financial planning, business finance, controllership and commercial finance.\n\n## GMM Pfaudler's Recent Financial Record\n\nAccording to akta.pro [company records](https://akta.pro/company-data), GMM Pfaudler reported consolidated revenue of ₹3,524 crores for FY26, a 10% year-on-year increase, and profit after tax of ₹52 crores, up 5%. Q4 FY26 revenue was ₹944 crore, 17% year-on-year growth. The records also show full-year FY26 order intake rose 20% to ₹3,714 crores, led by non-traditional segments including defence, oil and gas, and nuclear.\n\n## Results and Debt Moves Before the Appointment\n\nOn November 4, 2026, ScanX reported that GMM Pfaudler's Q2FY27 net profit was ₹35.13 crore, down 6.8% year-on-year, while revenue rose 18% to ₹1,064.62 crore. Order intake reached a record ₹1,198 crore, up 36% year-on-year, and EBITDA margin contracted to 10.29% on higher material costs and European losses.\n\nOn August 31, 2026, ScanX reported that wholly owned subsidiary GMM International S.a.rl. repaid EUR 7 million in outstanding debt to a group of lenders, funded entirely through internal accruals. On August 6, 2026, Investing.com reported that GMM Pfaudler's Q1 FY27 profit after tax rose 118% year-on-year to ₹22.1 crores as the company completed a transformation into four technology-focused global divisions.\n","publisher":{"name":"News for Agent","url":"https://newsforagent.com"}}